These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3037875)

  • 1. The pharmacokinetics of proguanil in human subjects following a single oral dose.
    Chiluba EM; Fletcher KA; Price AH
    Afr J Med Med Sci; 1987 Mar; 16(1):43-6. PubMed ID: 3037875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of chlorproguanil in man after a single oral dose of Lapudrine.
    Veenendaal JR; Edstein MD; Rieckmann KH
    Chemotherapy; 1988; 34(4):275-83. PubMed ID: 3208546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human pharmacokinetics of proguanil and its metabolites.
    Bygbjerg I; Ravn P; Rønn A; Flachs H; Hvidberg EF
    Trop Med Parasitol; 1987 Jun; 38(2):77-80. PubMed ID: 3629140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man.
    Edstein MD; Veenendaal JR; Scott HV; Rieckmann KH
    Chemotherapy; 1988; 34(5):385-92. PubMed ID: 3180907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of etofylline after intravenous and oral administration to humans.
    Zuidema J; Verhoeven J; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humans.
    Partovian C; Jacqz-Aigrain E; Keundjian A; Jaillon P; Funck-Brentano C
    Clin Pharmacol Ther; 1995 Sep; 58(3):257-63. PubMed ID: 7554698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis.
    Thapar MM; Ashton M; Lindegårdh N; Bergqvist Y; Nivelius S; Johansson I; Björkman A
    Eur J Clin Pharmacol; 2002 Apr; 58(1):19-27. PubMed ID: 11956669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma pharmacokinetics of cinmetacin following oral administration in healthy volunteers.
    Danesi R; Ducci M; Acerbi D; Del Tacca M
    Arzneimittelforschung; 1988 Jan; 38(1):129-31. PubMed ID: 3259136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of pioglitazone in Thai healthy subjects.
    Wittayalertpanya S; Chompootaweep S; Thaworn N
    J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
    Saghir SA; Clark AJ; McClymont EL; Staley JL
    Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma, erythrocyte and urine concentrations of chlorproguanil and two metabolites in man after different doses.
    Petersen E; Flachs H; Høgh B; Hanson AP; Björkman A; Hvidberg EF
    J Trop Med Hyg; 1991 Jun; 94(3):199-205. PubMed ID: 2051526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans.
    Funck-Brentano C; Bosco O; Jacqz-Aigrain E; Keundjian A; Jaillon P
    Clin Pharmacol Ther; 1992 May; 51(5):507-12. PubMed ID: 1587064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects.
    Wattanagoon Y; Taylor RB; Moody RR; Ochekpe NA; Looareesuwan S; White NJ
    Br J Clin Pharmacol; 1987 Dec; 24(6):775-80. PubMed ID: 3440097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A statistical analysis of the antimalarial activity of proguanil and cycloguanil in human volunteers.
    Yeo AE; Edstein MD; Shanks GD; Rieckmann KH
    Ann Trop Med Parasitol; 1994 Dec; 88(6):587-94. PubMed ID: 7893172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of pharmacokinetics of proguanil in healthy volunteers following concurrent administration of efavirenz.
    Soyinka JO; Onyeji CO
    Eur J Pharm Sci; 2010 Feb; 39(4):213-8. PubMed ID: 19961932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone.
    Edstein MD; Veenendaal JR; Rieckmann KH
    Chemotherapy; 1990; 36(3):169-76. PubMed ID: 2186899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multiple dose pharmacokinetics of proguanil.
    Helsby NA; Edwards G; Breckenridge AM; Ward SA
    Br J Clin Pharmacol; 1993 Jun; 35(6):653-6. PubMed ID: 8329294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.